Fig. 1From: Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysisPreferred Reporting Items for Systematic Reviews and Meta-analysis flow diagram: search and study selection process for this reviewBack to article page
